UnitedHealth Earnings Beat Expectations, Leading to Analyst Upgrades and Higher Price Targets
UnitedHealth Group (UNH) reported better-than-expected Q1 2026 earnings, prompting four major Wall Street firms to upgrade their ratings or raise price targets. The company's improved medical cost ratio and disciplined pricing strategy are seen as positive signs, though regulatory risks around Medicare Advantage remain a concern.
Topics: Analyst Upgrades Earnings Medicare Advantage Stock Price Movement Turnaround Strategy